The team behind the UK’s main COVID-19 vaccine, developed at Oxford University, is preparing to update the inoculation to be resistant to new strains of the virus.
British newspaper The Independent reported that the team is mobilizing this new effort in response to the variants seen in the UK, South Africa and elsewhere.
The efficacy of the current vaccine against the most common strains of COVID-19 is being assessed by scientists from the university, with preliminary results expected toward mid-February.
Prof. Sarah Gilbert, the team’s lead, said the researchers would not wait to discover the test’s results before acting, and instead are already synthesizing the new variants into the jab that is currently being rolled out nationwide.
Scientists at Oxford University are understood to be confident that their vaccine will not need to be adapted in response to the British variant, which was discovered last month after an especially rapid outbreak in Kent.
Data published by Pfizer and BioNTech, the producers of the other vaccine being provided in Britain, has indicated that their inoculation is resistant to the new COVID-19 strain.
More analysis is being conducted to assess whether it will be able to neutralize the newer South African and Brazilian variants.
A spokesperson from Oxford University said any necessary modifications would take “one day’s worth of work” before being grown in cell culture within a laboratory.